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Case Report
Case of Enterococcus cecorum Human Bacteremia,
United States
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Enterococcus cecorum rarely serves as a human pathogen, and only 6 cases of this microbe
inoculating humans have been documented. We present an elderly female with a marked
vascular history presenting with epigastric pain and diarrhea, followed by shaking chills.
Laboratory findings revealed leukocytosis, with imaging showing diffuse colonic thickening.
She had a bout of bloody diarrhea, raising the likelihood of ischemic colitis with her vascular
history. To our surprise, both sets of blood cultures drawn on admission grew Enterococcus
cecorum. This case is unique as it is the first documented case of E. cecorum human infection in the United States.
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Introduction

Enterococcus cecorum (E. cecorum) is a
gram-positive cocci bacterium that is found in
the intestinal tracts of many domestic animals
and poultry.1 Unlike Enterococcus faecalis that
is found in more than 90 percent of human
intestinal tracts, E. cecorum rarely serves as
a human pathogen, with documented cases
scarce.1 E. cecorum is not a known inhabitant of
a human’s gastrointestinal tract, urinary tract
or skin.2 Upon review of medical literature, only
6 cases of E. cecorum inoculating humans with
clinically significant disease were found. These
prior reported cases include patients with
peritonitis, endocarditis, pulmonary abscess
and septicemia.2-6 The portal of entry for this
organism has not been studied in detail, but
limited data show the possibility of a gastrointestinal source.7 We present an elderly female
with a striking vascular history presenting with
epigastric pain and diarrheal episode followed
by fever and shaking chills found to have bacteremia caused by E. cecorum.

Case Presentation

We present a case of an 80-year-old female
with a past medical history of infrarenal abdominal aortic aneurysm status post repair,
thoracic aortic aneurysm, lung cancer status
post lobectomy, peptic ulcer disease, chronic obstructive pulmonary disease, coronary
artery disease status post cardiac stenting and
ischemic colitis. The patient presented with
intermittent, non-reproducible epigastric pain
for the past 24 hours. The epigastric pain intermittently radiated between her shoulders and
was aggravated by anxiety and stress. This pain
was anxiety provoking to the patient as she had
similar complaints in the past and ended up
having life-threatening situations. In 2016, she
reported a similar presentation and was found
to have a superior mesenteric artery (SMA)
occlusion and underwent stenting. In 2017, she
reported having an episode of severe gastric
ulcer bleeding that required a massive transfusion protocol and intervention via esophagogastroduodenoscopy. Furthermore, she re-
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Table 1. Emergency Department Abnormal Laboratory Findings.
Test
Patient’s value
Serum leukocyte count
Neutrophil % of leukocyte count
Creatinine

4.8–10.8 x 109/L

87.1%

45–75%

1.76 mg/dl (acute)

0.6–1.2 mg/dl

ported a known 6.9 cm thoracic and abdominal
aortic aneurysm that was deemed inoperable.

icant change from the same imaging study 1
year prior.

During this visit, the epigastric pain was associated with lightheadedness, shortness of breath
and constipation. She became particularly concerned during the evening of her presentation
when she had an episode of non-bloody diarrhea described as ‘explosive’ that was followed
by the development of a subjective fever and
shaking chills. This episode prompted her to
present to the emergency department. Her initial vital signs showed a temperature of 98.4o F,
a heart rate of 58 beats per minute, blood pressure of 98/58 mmHg and oxygen saturation of
95% on 2 L nasal cannula. Abnormal laboratory
findings are shown in Table 1. Otherwise, her
complete blood count, comprehensive metabolic panel and urinalysis were unremarkable.

CT imaging of the abdomen/pelvis revealed
diffuse mild thickening of the colonic wall, considerably sparing the cecum with liquid stool
throughout. With the possibility of an infectious etiology as the source of the patient’s
presentation, 2 sets of blood and stool cultures
were collected, and empiric coverage with piperacillin/tazobactam was started. A urinalysis
was negative for leukocyte esterase, nitrites or
white blood cells. Gastroenterology was consulted, and the patient was admitted to the
progressive care unit.

Due to the patient’s pertinent history of
multiple vascular comorbidities, a computed
tomography angiogram of her chest (CTA) and
abdomen/pelvis was completed. (Figures 1 and
2) The massively enlarged thoracic aorta extended down into the left renal artery where an
aortic graft was placed. There was no evidence
of hematoma, gas, inflammation or any signif-

Figure 1. Emergency Department CTA, Chest.
496

Reference range

14.2 x 10 /L
9

In less than 24 hours, both blood cultures
began to grow gram-positive cocci in clusters,
pairs and chains. Infectious disease was consulted. Antibiotic therapy was deescalated to
intravenous (IV) ampicillin/sulbactam and a
transthoracic echocardiogram was completed
that did not reveal evidence of endocarditis.
While awaiting microbe identification, the
patient had an episode of bloody stool followed
by a watery, non-bloody pellet-like stool. Stool
studies from day 1 were negative for Shigella,
Salmonella, Aeromonas, Clostridium difficile and
Campylobacter.
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Figure 2. Emergency Department CTA, Abdomen/Pelvis.
On day 3, the organism on her blood cultures
was identified. In both sets, the blood cultures
grew E. cecorum. This organism was sensitive
to ampicillin and vancomycin and synergistic
with both streptomycin and gentamicin. Upon
further questioning, there was no clear source
of this organism as the patient denied interactions with poultry, domestic animals, recent
travel, abnormal exposures, new skin lesions
or changes to her diet. Repeat blood cultures
drawn 48 hours after the initial 2 sets of blood
cultures were drawn in the emergency department showed no growth. The patient was
started on oral amoxicillin on day 4. The leukocytosis resolved, and she had had no further
episodes of diarrhea, fevers or chills. She was
discharged home on day 5. In total, she received
3 days of IV antibiotic therapy and was transitioned onto oral amoxicillin every 12 hours for 14
days on discharge.

Discussion

There are less than 10 total reported cases of E.
cecorum infections in humans.2-7 This case report presents this typical poultry and domestic
animal pathogen causing bloodstream infection
in our human patient. Our patient’s diagnosis
was first confounded due to her massive aortic
aneurysm, history of gastric ulcer bleeding,
SMA occlusion and coronary artery disease.
Ischemic colitis was the presumed diagnosis
due to her history of colitis and her vascular
history. A colonoscopy was also not feasible.
The patient was a poor candidate for endoscopy due to adverse effects with prior anesthesia
and comorbidities. To our surprise, E. cecorum

grew in both sets of blood cultures with negative stool cultures. We were fortunate that our
patient improved with beta-lactam antibiotics
initiated on admission, as many enterococci
species are inherently resistant to many antibiotics, including penicillin.8
The purpose of this case is to bring awareness
to a potential rare human pathogen of the
Enterococcus genus. This bacterium’s human
infectivity, the portal of entry, severity and effect on morbidity/mortality is unknown.

Conclusion

To the best of our knowledge, this case is the
first reported since 2016 that reveals E. cecorum as a human pathogen, and it is the first to
occur in the United States. Recording cases in
the future involving this rare human pathogen
is of utmost importance in order to shed light
on its role in human disease processes.
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